More patients have access to medicines within the high-cost protection system

2 June 2020 - From today, patients who pick up prescription drugs at pharmacies will be able to switch to ...

Read more →

Health economic assessment of Vimizim in mucopolysaccharidosis type IVA (Morquio A syndrome)

29 May 2020 - TLV has developed a health economic knowledge base for the regions of the drug Vimizim (elosulfase alfa) ...

Read more →

TLV has decided to reconsider the subsidy status for certain drugs

26 May 2020 - TLV initiates a review for review of subsidy status for drugs that are part of one ...

Read more →

Health economic assessment of Bavencio and Inlyta

18 May 2020 - TLV has developed a health economic assessment for the regions regarding the combination of avelumab (Bavencio) and ...

Read more →

Camurus' Buvidal reimbursed in Sweden for the treatment of opioid dependence

14 May 2020 - Buvidal (buprenorphine) prolonged release injection receives reimbursement in Sweden from the 15 May 2020 after approval by ...

Read more →

Health economic assessment of Spravato in treatment resistant depression

14 May 2020 - TLV has developed a health economic knowledge base for the regions for Spravato (esketamine).  ...

Read more →

Third evaluation within the FINOSE collaboration

12 May 2020 - Together with the corresponding authorities in Finland and Norway, TLV has produced a joint evaluation report ...

Read more →

Health economic assessment of gene therapy Zynteglo in transfusion-dependent beta-thalassemia

11 May 2020 - TLV has developed a health-economic knowledge base for the Zynteglo gene therapy (autologous CD34-positive cells expressing the ...

Read more →

HyQvia gets a higher price

8 May 2020 - HyQvia 100 mg/mL solution for injection contains human immunoglobulin, which is an antibody used to strengthen ...

Read more →

Health economic assessment of Keytruda in head and neck cancer

29 April 2020 - TLV has developed a health economic knowledge base for the regions of the drug Keytruda (pembrolizumab).  ...

Read more →

Epidyolex is granted temporary subsidy

20 April 2020 - The TLV has decided that Epidyolex 100 mg /mL oral solution should be included in the ...

Read more →

Additional analysis of Kymriah in the treatment of patients with diffuse large-cell B-cell lymphoma

17 April 2020 - TLV has conducted an additional analysis of the earlier evaluation of Kymriah (tisagenleclucel) in the treatment ...

Read more →

The review shows that it is possible to lower the cost of medicines

3 April 2020 - There are opportunities to make savings on medicines.  ...

Read more →

Pharmacies may only dispense drugs for 90 days

1 April 2020 - As of today, April 1, pharmacies cannot deliver a larger amount of drug than the amount ...

Read more →

Health economic assessment of Keytruda in combination with Inlyta in kidney cell cancer

31 March 2020 - TLV has developed a health economic knowledge base for the regions for combination treatment with the drugs ...

Read more →